CLINICAL_TRIALS
research
· 2019-07-19
Clinical Trial Update: Retrospective Epidemiology Study Of ALK Rearrangement In Non-Small Cell Lung Cancer Patients In The Middle East & North Africa
Summary
Retrospective epidemiology study assessing ALK rearrangement in non-small cell lung cancer patients in the Middle East and North Africa.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Pfizer | Conditions: Non-small Cell Lung Cancer | Status: COMPLETED | Results posted: 2019-07-19